Search Results - Schecter S
- Showing 1 - 20 results of 43
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
P072: Use of tadalafil in MEGDEL syndrome by Daniel Schecter, Graeme Preston, Tamas Kozicz, Eva Morava-Kosicz
Published in Genetics in Medicine Open (2025-01-01)Get full text
Article -
7
-
8
A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies. by Pierre Duquette, Michael Yeung, Soukaïna Mouallif, Hamid Reza Nakhaipour, Paola Haddad, Robyn Schecter
Published in PLoS ONE (2019-01-01)Get full text
Article -
9
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia by Russell Clayton, Teresa Galas, Noreen Scherer, Jennifer Farmer, Nancy Ruiz, Mohamed Hamdani, Devin Schecter, David Bettoun
Published in Annals of Clinical and Translational Neurology (2024-03-01)Get full text
Article -
10
-
11
-
12
Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross‐sectional study by James J Jang, Aron I Schwarcz, Daniel A Amaez, Mark Woodward, Jeffrey W Olin, Marla J Keller, Alison D Schecter
Published in Journal of the International AIDS Society (2010-01-01)Get full text
Article -
13
11010 The diagnostic accuracy of procalcitonin for urinary tract infection in hospitalized older adults by Justin Choi, Kerry Meltzer, Anna Cornelius-Schecter, Assem Jabri, Matthew Simon, Matthew McCarthy, Lars Westblade, Saurabh Mehta, Zhen Zhao, Marshall Glesby
Published in Journal of Clinical and Translational Science (2021-03-01)Get full text
Article -
14
Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting by Winfried Alsdorf, Joris Diels, Francesca Ghilotti, Joao Mendes, Teresa Hernando, Patricia Cost, Jordan M Schecter, Nikoletta Lendvai, Nitin Patel, Ana Triguero, Margherita Ursi
Published in Journal of Comparative Effectiveness Research (2024-08-01)Article -
15
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma by Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, Annette Lam, Tito Roccia, Jordan M. Schecter, Patricia Cost, Lida Pacaud, Abbey Poirier, Gabriel Tremblay, Tommy Lan, Satish Valluri, Shaji Kumar
Published in BMC Cancer (2024-04-01)Get full text
Article -
16
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies by Rebecca Crawford, Katharine S. Gries, Satish Valluri, John Fastenau, Ross Morrison, Tzu‐Min Yeh, Yunsi Olyslager, Jenna D. Goldberg, Jordan M. Schecter, Carolyn C. Jackson, William Deraedt, Lynda Doward
Published in Cancer Reports (2022-11-01)Get full text
Article -
17
P46 SEER-MEDICARE DATABASE: REAL-WORLD TREATMENTS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED MULTIPLE MYELOMA TREATED WITH 1–3 PRIOR LINES OF THERAPY, INCLUDING... by H. Einsele, B. Dhakal, R. Potluri, J. Schecter, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, S. Nair, J. He, J. Voelker, P. Cost, S. Valluri, F. Yalniz, L. Pacaud, K. Yong
Published in HemaSphere (2023-05-01)Get full text
Article -
18
P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE by B. Dhakal, H. Einsele, R. Potluri, J. Schecter, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, S. Nair, J. He, N. Joseph, P. Cost, S. Valluri, F. Yalniz, L. Pacaud, K. Yong
Published in HemaSphere (2022-06-01)Get full text
Article -
19
P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES... by H. Einsele, B. Dhakal, J. M. Schecter, T. Roccia, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, K. Connors, K. Qi, A. Londhe, R. Carson, J. Voelker, P. Cost, S. Valluri, E. Florendo, L. Pacaud, K. Yong
Published in HemaSphere (2023-05-01)Get full text
Article -
20
P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 A... by O. Decaux, C. Hulin, A. Perrot, M. Macro, L. Frenzel, J. Diels, N. J. Perualila, F. Ghilotti, B. Haefliger, E. Goldsztajn, S. Vernet, J. Thevenon, M. Willaime, N. Texier, J. M. Schecter, D. Madduri, C. Jackson, S. Valluri, P. Moreau
Published in HemaSphere (2022-06-01)Get full text
Article
